Finally, we show that HuR overexpression totally blocked, while knocking down of HuR sensitized PPARα agonists to induce the expression of fatty acid catabolism genes, indicating HuR could be the key factor explaining mild effects of PPARα agonists in treating fatty liver diseases in human populations. This evidence concerns the gene ELAVL1 and fatty liver disease.